Intravenous proton pump inhibitors vs oral potassium competitive acid blockers before endoscopic treatment of bleeding peptic ulcers

doi:10.4253/wjge.v17.i6.104234

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-4)

Tables (1-3)

Sum=0

Jun 16, 2025 (publication date) through Jun 11, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Endosc. Jun 16, 2025; 17(6): 104234
Published online Jun 16, 2025. doi: 10.4253/wjge.v17.i6.104234

Open in New Tab Full Size Figure Download Figure

Figure 1 Study overview. PPIs: Proton pump inhibitors; PCABs: Potassium competitive acid blockers; EGD: Esophagogastroduodenoscopy.

Open in New Tab Full Size Figure Download Figure

Figure 2 Inclusion and exclusion criteria. GI: Gastrointestinal; ESD: Esophagogastroduodenoscopy; NVUGIB: Non-variceal upper gastrointestinal bleeding.

Open in New Tab Full Size Figure Download Figure

Figure 3 Study flowchart. NVUGIB: Non-variceal upper gastrointestinal bleeding; PPI: Proton pump inhibitor; PCAB: Potassium competitive acid blocker.

Open in New Tab Full Size Figure Download Figure

Figure 4 Comparison of outcomes between groups who received either proton pump inhibitor or potassium competitive acid blocker therapy. PCAB: Potassium competitive acid blocker; PPI: Proton pump inhibitor.

Citation: Lim NR, Chung WC. Intravenous proton pump inhibitors vs oral potassium competitive acid blockers before endoscopic treatment of bleeding peptic ulcers. World J Gastrointest Endosc 2025; 17(6): 104234
URL: https://www.wjgnet.com/1948-5190/full/v17/i6/104234.htm
DOI: https://dx.doi.org/10.4253/wjge.v17.i6.104234